Can AstraZeneca dispel doubts about its shots?
With the company caught up in murky data releases and public relations misfires, experts worry that the world may turn its back on a vaccine that still holds promise for combating the pandemic.
The AstraZeneca shot was supposed to be the vaccine for a couple of billion people. It is inexpensive at just a couple of dollars per dose and can be stored in an ordinary fridge unlike the mRNA vaccines. But after reports the shot may trigger a rare side effect, and the company’s string of communication blunders, public health officials worry that the people in some countries may have lost faith in the world’s most important vaccine.
Just one week after the news of a rare and potentially deadly blood clotting disorder led some countries to halt vaccinations, the NIH issued an unprecedented and very public reprimand over the company’s release of incomplete clinical trial results in the United States. Now many
